Serum biomarkers in valvular heart disease

Heart. 2018 Feb;104(4):349-358. doi: 10.1136/heartjnl-2016-310482. Epub 2017 Sep 19.

Authors

Syed Km Gardezi^{1

2}, Sean Coffey³, Bernard D Prendergast⁴, Saul G Myerson^{1

2}

Affiliations

¹ Department of Cardiology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
² Radcliffe Department of Medicine, Division of Cardiovascular Medicine, University of Oxford, Oxford, UK.
³ Department of Medicine, Dunedin School of Medicine, University of Otago, Otago, New Zealand.
⁴ Department of Cardiology, St Thomas' Hospital, London, UK.

PMID: 28928243
DOI: 10.1136/heartjnl-2016-310482

No abstract available

Keywords: aortic stenosis; biomarkers; left ventricle; mitral regurgitation; valvular heart disease.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers / blood
Cardiac Imaging Techniques / methods
Disease Management
Disease Progression
Heart Valve Diseases* / diagnosis
Heart Valve Diseases* / metabolism
Heart Valve Diseases* / physiopathology
Heart Valve Diseases* / therapy
Humans
Natriuretic Peptide, Brain / blood*
Patient Selection
Troponin / blood*

Substances

Biomarkers
Troponin
Natriuretic Peptide, Brain